The FDA announced the recall of more acne products due to contamination of benzene, a cancer-causing chemical.While the recalled products contained elevated levels of benzene, the FDA said the risk of ...

Discussion: The earlier acne is treated the more likely scarring will be minimised, so a proactive approach is ... However, it is still the only available treatment that targets all four ...

Separately from the FDA testing, makers of another acne treatment, Zapzyt Acne Treatment Gel, voluntarily recalled the product after doing its own evaluation. The rest of the products the FDA ...

Fact checked by Nick Blackmer Six popular acne treatments from name brands like La Roche-Posay, Proactive, and Walgreens have ...

Makeup company L’Oréal has recalled popular brand La Roche-Posay’s acne cream because it may contain benzene, a ...

The FDA said testing of certain acne products with benzoyl peroxide found elevated levels of benzene, a chemical linked to cancer.

Featured pricing is subject to change. Acne treatment just got a serious upgrade without drying out your skin. Meet Geologie’s Clear System, a medical-grade treatment to clear your skin without ...

Now more products have been recalled due to the same reason. Health reported Wednesday how L’Oréal took their popular La Roche-Posay Effaclar Duo acne treatment due to a potential benzene ...

The cream sells for $35.99 and according to their website, is “our best spot treatment for acne ... has also found benzene in other acne products, like Proactive, from stores like Target ...

From balancing schoolwork to dealing with dizzying hormone changes, the teenage experience is filled with obstacles. Perhaps the most common and frustrating of them all are frequent breakouts.

The FDA has recalled several acne treatments from brands including La Roche-Posay and Walgreens due to benzene contamination.

"It was just mortifying. You feel like it's the end of the world when that happens," Kendall Jenner tells PEOPLE exclusively about her struggle with acne Melody Chiu is an Executive Editorial ...